|
|
Office Locations:
|
200 Clarendon Street, 45th Floor
Boston, MA 02116
Phone: 857-305-1825
Fax: 857-305-1843
| |
|
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
5AM Ventures makes seed and early-stage investments in next-generation life science companies including biopharmaceuticals, drug delivery technologies and life science instruments. Founded in 2002 by former Bay City Capital principals, 5AM Ventures has offices in Boston and Menlo Park, CA. The 5AM team takes a hands-on approach to company building. In addition to holding board seats in the majority of its portfolio companies, 5AM is directly involved in company strategy, management recruiting, business development, and fundraising. The 5AM portfolio, built on advanced life science technologies, is diversified among innovative platforms, spinouts from established biotechnology and pharmaceutical companies, and companies developing near-term products. The firm currently has over $1.2 billion under management and is currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I. 5AM Ventures has 100 portfolio companies.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
